|
HECA expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.21600001973854E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.43380002210125E-09 |
| Normal-vs-Stage2 |
1.31480049070376E-10 |
| Normal-vs-Stage3 |
9.09380015734484E-10 |
| Normal-vs-Stage4 |
1.96909999417016E-09 |
| Stage1-vs-Stage2 |
8.588200E-02 |
| Stage1-vs-Stage3 |
2.608200E-01 |
| Stage1-vs-Stage4 |
2.317600E-01 |
| Stage2-vs-Stage3 |
4.212600E-01 |
| Stage2-vs-Stage4 |
6.668000E-01 |
| Stage3-vs-Stage4 |
7.890800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.23349996883348E-09 |
| Normal-vs-AfricanAmerican |
2.04859999999307E-05 |
| Normal-vs-Asian |
2.4095000439317E-09 |
| Caucasian-vs-AfricanAmerican |
3.866200E-01 |
| Caucasian-vs-Asian |
6.647200E-01 |
| AfricanAmerican-vs-Asian |
2.560800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.22759999335409E-09 |
| Normal-vs-Female |
7.22609971859356E-10 |
| Male-vs-Female |
9.839800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.60219999992373E-08 |
| Normal-vs-Age(41-60Yrs) |
5.09809972015773E-11 |
| Normal-vs-Age(61-80Yrs) |
1.3516999741725E-09 |
| Normal-vs-Age(81-100Yrs) |
3.875700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.563700E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.754570E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.599200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.402800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.256400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.448600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.242400E-01 |
| Classical-VS-Follicular |
1.857770E-02 |
| Classical-VS-Other |
1.316150E-01 |
| Classical-VS-Normal |
1.28520000197696E-08 |
| Tall-VS-Follicular |
8.027000E-01 |
| Tall-VS-Other |
4.269400E-01 |
| Tall-VS-Normal |
7.10209999699174E-08 |
| Follicular-VS-Other |
4.198200E-01 |
| Follicular-VS-Normal |
1.63570046396444E-10 |
| Other-VS-Normal |
1.32150000053954E-07 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.04940542103805E-11 |
| Normal-vs-N1 |
5.45669953666561E-10 |
| N0-vs-N1 |
9.671400E-01 |
|
|
